Peter Markus

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer.

Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer.

Journal: Nature communications
Published: October 16, 2023

Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study.

Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study.

Journal: ESMO open
Published: September 03, 2023

Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting.

Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting.

Journal: Journal of cancer research and clinical oncology
Published: July 05, 2023

Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer.

Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer.

Journal: ESMO open
Published: February 04, 2023

A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO).

A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO).

Journal: Oncology research and treatment
Published: November 24, 2022

A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma.

A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma.

Journal: Journal of cancer research and clinical oncology
Published: September 06, 2022

Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer.

Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer.

Journal: Journal of cachexia, sarcopenia and muscle
Published: August 16, 2022

Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols.

Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols.

Journal: Oncology research and treatment
Published: August 15, 2022

Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.

Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.

Journal: Journal of cancer research and clinical oncology
Published: August 05, 2022

Multimodal survival prediction in advanced pancreatic cancer using machine learning.

Multimodal survival prediction in advanced pancreatic cancer using machine learning.

Journal: ESMO open
Published: April 27, 2022

Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression.

Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression.

Journal: Nature communications
Published: March 07, 2021

Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy.

Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy.

Journal: Journal of cancer research and clinical oncology
Published: May 13, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026